Overview Financials News + Filings Key Docs Charts Ownership Insiders
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Quarterly results
|
|
MUSTANG BIO, INC. (MBIO)
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 08/14/2023 |
8-K
| Quarterly results |
| 05/12/2023 |
8-K
| Quarterly results |
| 11/14/2022 |
8-K
| Quarterly results |
| 08/11/2022 |
8-K
| Quarterly results |
| 05/12/2022 |
8-K
| Quarterly results |
| 11/12/2021 |
8-K
| Quarterly results|
Docs:
|
"MUSTANG BIO, INC. Condensed Balance Sheets September 30, December 31, 2021 2020 ASSETS Current Assets: Cash and cash equivalents $ 120,879 $ 97,804 Other receivables - related party 41 15 Prepaid expenses and other current assets 1,028 1,715 Total current assets 121,948 99,534 Property, plant and equipment, net 9,418 7,529 Fixed assets - construction in process 1,019 499 Restricted cash 1,000 1,000 Other assets 254 250 Operating lease right-of-use asset, net 1,067 1,088 Total Assets $ 134,706 $ 109,900 LIABILITIES AND STOCKHOLDERS’ EQUITY Current Liabilities: Accounts payable and accrued expenses $ 9,834 $ 8,747 Payables and accrued expenses - related party 296 490 Operating lease liabilities - short-term 329 278 Total current liabilities 10,459 9,515 Deferred income 270 — Operating lease ..." |
|
| 08/16/2021 |
8-K
| Quarterly results|
Docs:
|
"MUSTANG BIO, INC. Condensed Balance Sheets June 30, December 31, 2021 2020 ASSETS Current Assets: Cash and cash equivalents $ 129,923 $ 97,804 Other receivables - related party 32 15 Prepaid expenses and other current assets 1,386 1,715 Total current assets 131,341 99,534 Property, plant and equipment, net 7,155 7,529 Fixed assets - construction in process 2,355 499 Restricted cash 1,000 1,000 Other assets 255 250 Operating lease right-of-use asset, net 1,101 1,088 Total Assets $ 143,207 $ 109,900 LIABILITIES AND STOCKHOLDERS’ EQUITY Current Liabilities: Accounts payable and accrued expenses $ 5,766 $ 8,747 Payables and accrued expenses - related party 249 490 Operating lease liabilities - short-term 346 278 Total current liabilities 6,361 9,515 Operating lease liabilities - long-term 1,82..." |
|
| 11/06/2020 |
8-K
| Quarterly results|
Docs:
|
"MUSTANG BIO, INC. Condensed Balance Sheets September 30, December 31, 2020 2019 ASSETS Current Assets: Cash and cash equivalents $ 75,251 $ 61,413 Other receivables - related party 37 19 Prepaid expenses and other current assets 344 1,631 Total current assets 75,632 63,063 Property, plant and equipment, net 7,250 6,779 Fixed assets - construction in process 821 1,157 Restricted cash 1,000 1,000 Other assets 250 250 Operating lease right-of-use asset, net 1,115 1,196 Total Assets $ 86,068 $ 73,445 LIABILITIES AND STOCKHOLDERS’ EQUITY Current Liabilities: Short-term notes payable $ — $ 1,250 Accounts payable and accrued expenses 7,054 5,668 Payables and accrued expenses - related party 305 596 Operating lease liabilities - short-term 271 257 Total current liabilities 7,630 7,771 Notes payabl..." |
|
| 08/10/2020 |
8-K
| Quarterly results |
| 05/11/2020 |
8-K
| Quarterly results|
Docs:
|
"MUSTANG BIO, INC. Condensed Balance Sheets March 31, December 31, 2020 2019 ASSETS Current Assets: Cash and cash equivalents $ 55,814 $ 61,413 Other receivables - related party 14 19 Prepaid expenses and other current assets 1,877 1,631 Total current assets 57,705 63,063 Property, plant and equipment, net 7,729 6,779 Fixed assets - construction in process 712 1,157 Restricted cash 1,000 1,000 Other assets 250 250 Operating lease right-of-use asset, net 1,165 1,196 Total Assets $ 68,561 $ 73,445 LIABILITIES AND STOCKHOLDERS' EQUITY Current Liabilities: Short-term notes payable $ 3,125 $ 1,250 Accounts payable and accrued expenses 6,107 5,668 Payables and accrued expenses - related party 546 596 Operating lease liabilities - short-term 257 257 Total current liabilities 10,035 7,771 Notes pay..." |
|
| 11/12/2019 |
8-K
| Quarterly results |
| 08/09/2019 |
8-K
| Quarterly results |
| 05/10/2019 |
8-K
| Quarterly results |
| 08/13/2018 |
8-K
| Quarterly results|
Docs:
|
"MUSTANG BIO, INC. Condensed Balance Sheets June 30, December 31, 2018 2017 ASSETS Current Assets: Cash and cash equivalents $ 11,744 $ 34,975 Short-term investments 35,000 26,002 Interest receivable on short-term investments 409 106 Prepaid expenses 965 278 Total current assets 48,118 61,361 Property, plant and equipment, net 5,672 140 Fixed assets - construction in process 864 1,241 Restricted cash 500 500 Other assets 521 251 Total Assets $ 55,675 $ 63,493 LIABILITIES AND STOCKHOLDERS' EQUITY Current Liabilities: Accounts payable and accrued expenses $ 3,488 $ 3,474 Payables and accrued expenses - related party 187 137 Total current liabilities 3,675 3,611 Deferred Rent Payable 395 50 Total Liabilities 4,070 3,661 Commitments and Contingencies Stockholders' Equity Preferred stock , 2,000..." |
|
| 05/14/2018 |
8-K
| Quarterly results|
Docs:
|
"MUSTANG BIO, INC. Condensed Balance Sheets March 31, December 31, 2018 2017 ASSETS Current Assets: Cash and cash equivalents $ 17,755 $ 34,975 Short-term investments 37,002 26,002 Interest receivable on short-term investments 203 106 Prepaid expenses 666 278 Total current assets 55,626 61,361 Property, plant and equipment, net 133 140 Fixed assets - construction in process 4,237 1,241 Restricted cash 500 500 Other assets 594 251 Total Assets $ 61,090 $ 63,493 LIABILITIES AND STOCKHOLDERS' EQUITY Current Liabilities: Accounts payable and accrued expenses $ 5,007 $ 3,474 Payables and accrued expenses - related party 316 137 Total Current Liabilities 5,323 3,611 Deferred Rent Payable 125 50 Total Liabilities 5,448 3,661 Commitments and Contingencies Stockholders' Equity Preferred stock , 2,00..." |
|
| 11/14/2017 |
8-K
| Quarterly results |
| 08/14/2017 |
8-K
| Quarterly results |
|
|